Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
מצבים רפואיים
Hepatocellular Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Queen Elizabeth Hospital, Birmingham, United Kingdom
Contact: Principal Investigator (Yuk-Ting Ma)Addenbrooke's Hospital, Cambridge, United Kingdom
Contact: Study coordinator (Bristi Basu)Western General Hospital, Edinburgh, United Kingdom
Contact: Principal Investigator (Alan Christie)Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Contact: Principal Investigator (Jeff Evans)St James's Hospital, Leeds, United Kingdom
Contact: Principal Investigator (Daniel Swinson)Clatterbridge Cancer Centre, Liverpool, United Kingdom
Contact: Principal Investigator (Daniel Palmer)Hammersmith Hospital, London, United Kingdom
Contact: Principal Investigator (Rohini Sharma)King's College Hospital, London, United Kingdom
Contact: Study coordinator (Paul Ross)Royal Free Hospital, London, United Kingdom
Contact: Principal Investigator (Tim Meyer)The Christie NHS Foundation Trust, Manchester, United Kingdom
Contact: Principal Investigator (Richard Hubner)Freeman Hospital, Newcastle upon Tyne, United Kingdom
Contact: Principal Investigator (Sanjay Pandanaboyana)
מובילי המחקר
Tim Meyer, BSc MBBS PhD FRCP
Principal Investigator
University College, London